ReP USP - Resultado da busca

Artigo de periodico
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms (2022)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Pereira, Luiz Miguel ; Berzoti-Coelho, Maria Gabriela ; Berbel, Giovana Michelassi; Baroni, Luciana ; Pereira, Tathiane Maistro Malta ; Tognon, Raquel; Nunes, Natália de Souza ; Souto, Elizabeth Xisto; Pontes, Lorena Lobo de Figueiredo ; Natsui, Ana Patrícia Yatsuda ; Castro, Fabíola Attié de
Fonte: Medical Oncology. Unidades: FCFRP, FMRP, ESALQ, FFCLRP, IQ
Assuntos: APOPTOSE, EXPRESSÃO GÊNICA, HIPOTÁLAMO, NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, v. 39, n. 5, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12032-022-01696-x. Acesso em: 05 out. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Pereira, L. M., Berzoti-Coelho, M. G., Berbel, G. M., Baroni, L., et al. (2022). Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, 39( 5), 1-11. doi:10.1007/s12032-022-01696-x
NLM
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Vancouver
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Artigo de periodico
Type I and II interferon are associated with high expression of the hippo pathway family members (2020)
Sciescia, Bianca; Tognon, Raquel; Nunes, Natália de Souza; Malta, Tathiane Maistro; Frantz, Fabiani Gai ; Castro, Fabíola Attié de ; Cacemiro, Maira da Costa
Fonte: Journal of Clinical & Cellular Immunology. Unidade: FCFRP
Assuntos: INFLAMAÇÃO, CITOCINAS, QUIMIOCINAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCIESCIA, Bianca et al. Type I and II interferon are associated with high expression of the hippo pathway family members. Journal of Clinical & Cellular Immunology, v. 11, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.35248/2155-9899.20.11:585. Acesso em: 05 out. 2024.
APA
Sciescia, B., Tognon, R., Nunes, N. de S., Malta, T. M., Frantz, F. G., Castro, F. A. de, & Cacemiro, M. da C. (2020). Type I and II interferon are associated with high expression of the hippo pathway family members. Journal of Clinical & Cellular Immunology, 11( 1). doi:10.35248/2155-9899.20.11:585
NLM
Sciescia B, Tognon R, Nunes N de S, Malta TM, Frantz FG, Castro FA de, Cacemiro M da C. Type I and II interferon are associated with high expression of the hippo pathway family members [Internet]. Journal of Clinical & Cellular Immunology. 2020 ; 11( 1):[citado 2024 out. 05 ] Available from: https://doi.org/10.35248/2155-9899.20.11:585
Vancouver
Sciescia B, Tognon R, Nunes N de S, Malta TM, Frantz FG, Castro FA de, Cacemiro M da C. Type I and II interferon are associated with high expression of the hippo pathway family members [Internet]. Journal of Clinical & Cellular Immunology. 2020 ; 11( 1):[citado 2024 out. 05 ] Available from: https://doi.org/10.35248/2155-9899.20.11:585
Artigo de periodico
A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays (2020)
Tognon, Raquel; Silva, Danillo Cunha de Almeida e ; Rey, Rita Andraos; Ristov, Mitko; Ambrósio, Luciana; Almeida, Felipe Campos de ; Nunes, Natália de Souza; Souto, Elizabeth Xisto; Perobelli, Leila de Lourdes; Simões, Belinda Pinto ; Guthy, Daniel Alexander; Radimerski, Thomas; Castro, Fabíola Attié de
Fonte: Leukemia & Lymphoma. Unidades: FMRP, FCFRP, BIOINFORMÁTICA
Assuntos: NEOPLASIAS, MUTAÇÃO GENÉTICA, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, v. 61, n. 13, p. 3052-3065, 2020Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1805110. Acesso em: 05 out. 2024.
APA
Tognon, R., Silva, D. C. de A. e, Rey, R. A., Ristov, M., Ambrósio, L., Almeida, F. C. de, et al. (2020). A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, 61( 13), 3052-3065. doi:10.1080/10428194.2020.1805110
NLM
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 out. 05 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Vancouver
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 out. 05 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Artigo de periodico
Differential cytokine network profile in polycythemia vera and secondary polycythemia (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Coelho, Maria Gabriela Berzoti; Tognon, Raquel; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pereira, Ítalo Sousa; Sartori, Daniela Carlos ; Faccioli, Lucia Helena ; Pontes, Lorena Lobo de Figueiredo ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Fonte: Scientific Reports. Unidades: FMRP, FCFRP
Assuntos: INTERLEUCINAS, TRANSTORNOS MIELOPROLIFERATIVOS, FISIOPATOLOGIA, CITOCINAS, NEOPLASIAS, MORTALIDADE, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, v. 10, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-63680-7. Acesso em: 05 out. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Coelho, M. G. B., Tognon, R., Nunes, N. de S., Simões, B. P., et al. (2020). Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, 10, 1-7. doi:10.1038/s41598-020-63680-7
NLM
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 out. 05 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Vancouver
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 out. 05 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Artigo de periodico
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation (2018)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Tognon, Raquel ; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pontes, Lorena Lobo de Figueiredo ; Catto, Luiz Fernando Bazzo ; Traina, Fabiola ; Souto, Elizabeth Xisto; Zambuzi, Fabiana Albani ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Fonte: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FCFRP
Assuntos: CÉLULAS-TRONCO, INFLAMAÇÃO, CITOCINAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, v. 40, n. 2, p. 120-131, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2017.12.003. Acesso em: 05 out. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Tognon, R., Nunes, N. de S., Simões, B. P., Pontes, L. L. de F., et al. (2018). Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, 40( 2), 120-131. doi:10.1016/j.htct.2017.12.003
NLM
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Vancouver
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Artigo de periodico
Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy (2015)
Ferreira, Aline Fernanda; Oliveira, Gislane Lelis Vilela de; Tognon, Raquel; Collassanti, Maria Dulce S.; Zanichelli, Maria Aparecida; Hamerschlak, Nelson; Souza, Ana Maria de; Covas, Dimas Tadeu; Kashima, Simone; Castro, Fabíola Attié de
Fonte: Acta Haematologica. Unidades: FCFRP, FMRP
Assuntos: APOPTOSE, LEUCEMIA MIELOIDE, EXPRESSÃO GÊNICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Aline Fernanda et al. Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy. Acta Haematologica, v. 133, n. 4, p. 354-364, 2015Tradução . . Disponível em: https://doi.org/10.1159/000369446. Acesso em: 05 out. 2024.
APA
Ferreira, A. F., Oliveira, G. L. V. de, Tognon, R., Collassanti, M. D. S., Zanichelli, M. A., Hamerschlak, N., et al. (2015). Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy. Acta Haematologica, 133( 4), 354-364. doi:10.1159/000369446
NLM
Ferreira AF, Oliveira GLV de, Tognon R, Collassanti MDS, Zanichelli MA, Hamerschlak N, Souza AM de, Covas DT, Kashima S, Castro FA de. Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy [Internet]. Acta Haematologica. 2015 ; 133( 4): 354-364.[citado 2024 out. 05 ] Available from: https://doi.org/10.1159/000369446
Vancouver
Ferreira AF, Oliveira GLV de, Tognon R, Collassanti MDS, Zanichelli MA, Hamerschlak N, Souza AM de, Covas DT, Kashima S, Castro FA de. Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy [Internet]. Acta Haematologica. 2015 ; 133( 4): 354-364.[citado 2024 out. 05 ] Available from: https://doi.org/10.1159/000369446
Artigo de periodico-carta/editorial
Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] (2013)
Nunes, Natália S; Tognon, Raquel; Moura, Livia G.; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth X.; Zanichelli, Maria A.; Simoes, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Fonte: Leukemia and Lymphoma. Unidades: FMRP, FCFRP
Assuntos: EXPRESSÃO GÊNICA, APOPTOSE, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Natália S et al. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3109/10428194.2013.767453. Acesso em: 05 out. 2024. , 2013
APA
Nunes, N. S., Tognon, R., Moura, L. G., Kashima, S., Covas, D. T., Santana, M., et al. (2013). Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3109/10428194.2013.767453
NLM
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 out. 05 ] Available from: https://doi.org/10.3109/10428194.2013.767453
Vancouver
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 out. 05 ] Available from: https://doi.org/10.3109/10428194.2013.767453
Artigo de periodico
Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis (2012)
Tognon, Raquel; Gasparotto, Elainy P. L.; Neves, Renata P.; Nunes, Natália S.; Ferreira, Aline F.; Palma, Patrícia V. B.; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth X.; Zanichelli, Maria Aparecida; Simoes, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Fonte: Journal of Hematology and Oncology. Unidades: FMRP, FCFRP
Assuntos: APOPTOSE, PROTEÍNAS DA MEMBRANA (METABOLISMO), EXPRESSÃO GÊNICA, WESTERN BLOTTING, METAPLASIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis. Journal of Hematology and Oncology, v. 5, 2012Tradução . . Disponível em: https://doi.org/10.1186/1756-8722-5-2. Acesso em: 05 out. 2024.
APA
Tognon, R., Gasparotto, E. P. L., Neves, R. P., Nunes, N. S., Ferreira, A. F., Palma, P. V. B., et al. (2012). Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis. Journal of Hematology and Oncology, 5. doi:10.1186/1756-8722-5-2
NLM
Tognon R, Gasparotto EPL, Neves RP, Nunes NS, Ferreira AF, Palma PVB, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis [Internet]. Journal of Hematology and Oncology. 2012 ; 5[citado 2024 out. 05 ] Available from: https://doi.org/10.1186/1756-8722-5-2
Vancouver
Tognon R, Gasparotto EPL, Neves RP, Nunes NS, Ferreira AF, Palma PVB, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis [Internet]. Journal of Hematology and Oncology. 2012 ; 5[citado 2024 out. 05 ] Available from: https://doi.org/10.1186/1756-8722-5-2
Artigo de periodico
Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases (2011)
Tognon, Raquel; Gasparotto, Elainy Patrícia Lino; Leroy, Janine Marie Gisele; Oliveira, Gislane Lelis Vilela; Neves, Renata Peres; Carrara, Rita de Cassia Viu; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth Xisto; Zanichelli, Maria Aparecida; Velano, Carlos Eduardo Engel; Simoes, Belinda Pinto; Alberto, Fernando Lopes; Miyashiro, Kozue; Souza, Ana Maria de; Amarante-Mendes, João Gustavo Pessini ; Castro, Fabíola Attié de
Fonte: Journal of Clinical Pathology. Unidades: FMRP, FCFRP, ICB
Assuntos: TRANSTORNOS MIELOPROLIFERATIVOS, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases. Journal of Clinical Pathology, v. 64, n. 1, p. 75-82, 2011Tradução . . Disponível em: https://doi.org/10.1136/jcp.2010.080895. Acesso em: 05 out. 2024.
APA
Tognon, R., Gasparotto, E. P. L., Leroy, J. M. G., Oliveira, G. L. V., Neves, R. P., Carrara, R. de C. V., et al. (2011). Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases. Journal of Clinical Pathology, 64( 1), 75-82. doi:10.1136/jcp.2010.080895
NLM
Tognon R, Gasparotto EPL, Leroy JMG, Oliveira GLV, Neves RP, Carrara R de CV, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Velano CEE, Simoes BP, Alberto FL, Miyashiro K, Souza AM de, Amarante-Mendes JGP, Castro FA de. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases [Internet]. Journal of Clinical Pathology. 2011 ; 64( 1): 75-82.[citado 2024 out. 05 ] Available from: https://doi.org/10.1136/jcp.2010.080895
Vancouver
Tognon R, Gasparotto EPL, Leroy JMG, Oliveira GLV, Neves RP, Carrara R de CV, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Velano CEE, Simoes BP, Alberto FL, Miyashiro K, Souza AM de, Amarante-Mendes JGP, Castro FA de. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases [Internet]. Journal of Clinical Pathology. 2011 ; 64( 1): 75-82.[citado 2024 out. 05 ] Available from: https://doi.org/10.1136/jcp.2010.080895
Artigo de periodico
Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients (2011)
Gasparotto, Elainy Patricia Lino; Tognon, Raquel; Ferreira, Aline Fernanda; Oliveira, Gislane Lelis Vilela; Palma, Patrícia Vianna Bonini; Zanichelli, Maria Aparecida; Souto, Elizabeth Xisto; Velano, Carlos Eduardo Engel; Simoes, Belinda Pinto; Carrara, Rita de Cassia Viu; Kashima, Simone; Covas, Dimas Tadeu; Castro, Fabíola Attié de; Souza, Ana Maria de
Fonte: BJPS - Brazilian Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Assuntos: POLICITEMIA, MUTAÇÃO GENÉTICA, EXPRESSÃO GÊNICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTTO, Elainy Patricia Lino et al. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients. BJPS - Brazilian Journal of Pharmaceutical Sciences, v. 47, n. 4, p. 873-884, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1984-82502011000400025. Acesso em: 05 out. 2024.
APA
Gasparotto, E. P. L., Tognon, R., Ferreira, A. F., Oliveira, G. L. V., Palma, P. V. B., Zanichelli, M. A., et al. (2011). Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients. BJPS - Brazilian Journal of Pharmaceutical Sciences, 47( 4), 873-884. doi:10.1590/S1984-82502011000400025
NLM
Gasparotto EPL, Tognon R, Ferreira AF, Oliveira GLV, Palma PVB, Zanichelli MA, Souto EX, Velano CEE, Simoes BP, Carrara R de CV, Kashima S, Covas DT, Castro FA de, Souza AM de. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients [Internet]. BJPS - Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47( 4): 873-884.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/S1984-82502011000400025
Vancouver
Gasparotto EPL, Tognon R, Ferreira AF, Oliveira GLV, Palma PVB, Zanichelli MA, Souto EX, Velano CEE, Simoes BP, Carrara R de CV, Kashima S, Covas DT, Castro FA de, Souza AM de. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients [Internet]. BJPS - Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47( 4): 873-884.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/S1984-82502011000400025
Trabalho de evento-resumo
Efeito do veneno bruto de Bothrops pirajai em células BCR-ABL+ (2009)
Neves, Renata Peres; Ayres, Lorena Rocha; Burin, Sandra Mara; Tognon, Raquel; Sampaio, Suely Vilela; Soares, Andreimar Martins; Castro, Fabíola Attié de
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica (SIICUSP). Unidade: FCFRP
Assuntos: VENENOS DE ORIGEM ANIMAL, APOPTOSE, FARMACOLOGIA, DOENÇAS HEMATOLÓGICAS (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Renata Peres et al. Efeito do veneno bruto de Bothrops pirajai em células BCR-ABL+. 2009, Anais.. São Paulo: USP, 2009. . Acesso em: 05 out. 2024.
APA
Neves, R. P., Ayres, L. R., Burin, S. M., Tognon, R., Sampaio, S. V., Soares, A. M., & Castro, F. A. de. (2009). Efeito do veneno bruto de Bothrops pirajai em células BCR-ABL+. In Resumos. São Paulo: USP.
NLM
Neves RP, Ayres LR, Burin SM, Tognon R, Sampaio SV, Soares AM, Castro FA de. Efeito do veneno bruto de Bothrops pirajai em células BCR-ABL+. Resumos. 2009 ;[citado 2024 out. 05 ]
Vancouver
Neves RP, Ayres LR, Burin SM, Tognon R, Sampaio SV, Soares AM, Castro FA de. Efeito do veneno bruto de Bothrops pirajai em células BCR-ABL+. Resumos. 2009 ;[citado 2024 out. 05 ]
Trabalho de evento-resumo
Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia (2007)
Gasparotto, Elainy P. L.; Carrara, Rita de Cássia Viu; Tognon, Raquel; Ferreira, Aline F.; Oliveira, Gislaine L. V. de; Souto, Elizabeth X.; Zanichelli, Maria A.; Simões, Belinda P.; Velano, Carlos; Kashima, Simone; Covas, Dimas Tadeu; Castro, Fabíola Attié de; Souza, Ana Maria de Souza
Fonte: Abstract. Nome do evento: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FMRP, FCFRP
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTTO, Elainy P. L. et al. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 05 out. 2024.
APA
Gasparotto, E. P. L., Carrara, R. de C. V., Tognon, R., Ferreira, A. F., Oliveira, G. L. V. de, Souto, E. X., et al. (2007). Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. In Abstract. São Paulo: ABCF.
NLM
Gasparotto EPL, Carrara R de CV, Tognon R, Ferreira AF, Oliveira GLV de, Souto EX, Zanichelli MA, Simões BP, Velano C, Kashima S, Covas DT, Castro FA de, Souza AM de S. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. Abstract. 2007 ;[citado 2024 out. 05 ]
Vancouver
Gasparotto EPL, Carrara R de CV, Tognon R, Ferreira AF, Oliveira GLV de, Souto EX, Zanichelli MA, Simões BP, Velano C, Kashima S, Covas DT, Castro FA de, Souza AM de S. Differential expression of the flice-inhibitory protein, c-flip, in cd34+ cells myelogenous leukemia, polycythemia vera and essential thombocythemia. Abstract. 2007 ;[citado 2024 out. 05 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada